32.JPG)
Antibody Discovery Market Size is valued at USD 2.07 billion in 2024 and is predicted to reach USD 5.42 billion by the year 2034 at a 10.2% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Antibody discovery refers to the process of locating new antibodies. The method aims to identify diagnostic or therapeutic antibodies with target-binding and detection capabilities. The employment of hybridoma technology and phage display is commonplace in antibody development. This approach is essential for developing new medicines, vaccines, diagnostic tools, and other therapeutic applications because it allows researchers to create antibodies that recognize and target specific antigens. Humanized, chimeric, murine, and human antibodies are among the many types produced.
The antibody discovery industry is booming with the concerning increase in the incidence of long-term health problems like cancer, diabetes, heart disease, and autoimmune disorders. Antibody discovery services are in high demand because chronic diseases and the subsequent need for appropriate treatments are becoming more common. Furthermore, rising consumer awareness of personalized treatment is expected to propel the antibody discovery industry. Personalized medicine aims to tailor medical treatment by evaluating preexisting biological data using genetic and biomarker tests. The creation of disease-specific antibodies is a key component of personalized medicine.
However, the market growth is hampered by the high-cost criteria for the safety and health of the antibody discovery market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity acrylic acid because the industry is expected to be constrained by the high expenses linked to the antibody discovery process, which will prevent widespread adoption. The market's growth is expected to be hindered by this factor throughout the predicted period. Antibody development was greatly affected by the COVID-19 pandemic. With increased funding for research, technological advancements, and new methodologies, scientists have made tremendous progress toward identifying efficient and selective antibodies. Antibody discovery is expected to experience a surge in the worldwide market because of the COVID-19 pandemic.
The antibody discovery market can be segmented across several key parameters By Antibody Discovery Step, By Antibody Discovery Method, By Nature of Antibody, By Therapeutic Area, By Type of Antibody, By End-User. Based on the antibody discovery step, it includes hit generation, lead selection, and lead optimization. When categorized by the method of discovery, the primary approaches are hybridoma-based methods, phage display library-based methods, transgenic animal-based methods, yeast display-based methods, single cell-based methods, and other emerging techniques.
In terms of the nature of the antibody, they can be classified as human antibodies, humanized antibodies, chimeric antibodies, or murine antibodies. The therapeutic area further segments the market into oncological disorders, immunological disorders, infectious diseases, cardiovascular disorders, neurological disorders, and other related conditions.
By type, antibodies can be monoclonal antibodies, bispecific antibodies, antibody drug conjugates, immunoconjugates, or other specialized formats. Finally, based on the end-user, the market is divided into in-house players (such as pharmaceutical and biotech companies) and contract research organizations (CROs) that offer antibody discovery services.
The murine antibody industry makes up the bulk of acrylic acid ester usage. Because of their long history of important use in research and therapeutic development, murine antibodies are a treasure trove of information and resources. Murine antibodies are just as important and useful for early screening and research, especially in countries like the US, Germany, the U.K., China, and India.
The North American antibody discovery market is expected to register the highest market share in revenue in the near future. It can be attributed to the growth in cancer rates, the robust antibody discovery business, and the innovative nature of the research and development sector's technological foundation. In addition, Asia Pacific is projected to grow rapidly in the global antibody discovery market because chronic diseases, like cardiovascular disease, are becoming more common. The increasing prevalence of cardiovascular illness has prompted the development of novel antibodies, driving this sector's growth.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 2.07 Bn |
|
Revenue Forecast In 2034 |
USD 5.42 Bn |
|
Growth Rate CAGR |
CAGR of 10.2% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Antibody Discovery Step, By Antibody Discovery Method, By Nature of Antibody, By Therapeutic Area, By Type of Antibody, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Danaher Corporation, Evotec, Biocytogen, Genscript Technology Corporation, Eurofins Scientific, Creative Biolabs, Charles River Laboratories, Sartorius AG, Twist Bioscience, and Fairjourney Biologics S.A. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Antibody Discovery Market Snapshot
Chapter 4. Global Antibody Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Antibody Discovery Step Estimates & Trend Analysis
5.1. By Antibody Discovery Step, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Antibody Discovery Step:
5.2.1. Hit Generation
5.2.2. Lead Selection
5.2.3. Lead Optimization
Chapter 6. Market Segmentation 2: By Antibody Discovery Method Estimates & Trend Analysis
6.1. By Antibody Discovery Method & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Antibody Discovery Method:
6.2.1. Hybridoma-based Methods
6.2.2. Phage Display Library-based Methods
6.2.3. Transgenic Animal-based Methods
6.2.4. Yeast Display-based Methods
6.2.5. Single Cell-based Methods
6.2.6. Other Methods
Chapter 7. Market Segmentation 3: By Nature of Antibody Estimates & Trend Analysis
7.1. By Nature of Antibody & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Nature of Antibody:
7.2.1. Human Antibodies
7.2.2. Humanized Antibodies
7.2.3. Chimeric Antibodies
7.2.4. Murine Antibodies
Chapter 8. Market Segmentation 4: By Therapeutic Area Estimates & Trend Analysis
8.1. By Therapeutic Area & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
8.2.1. Hybridoma-based Methods
8.2.2. Phage Display Library-based Methods
8.2.3. Transgenic Animal-based Methods
8.2.4. Yeast Display-based Methods
8.2.5. Single Cell-based Methods
8.2.6. Other Methods
Chapter 9. Market Segmentation 5: By Type of Antibody Estimates & Trend Analysis
9.1. By Type of Antibody & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Antibody:
9.2.1. Monoclonal Antibodies
9.2.2. Bispecific Antibodies
9.2.3. Antibody Drug Conjugates
9.2.4. Immunoconjugates
9.2.5. Other Antibodies
Chapter 10. Market Segmentation 6: By End User Estimates & Trend Analysis
10.1. By End User & Market Share, 2024 & 2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
10.2.1. In-house Players
10.2.2. Contract Research Organizations
Chapter 11. Antibody Discovery Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Antibody Discovery Step, 2021-2034
11.1.2. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Antibody Discovery Method, 2021-2034
11.1.3. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.1.4. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.1.5. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.1.6. America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
11.1.7. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, 2021-2034
11.2.2. Europe Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, 2021-2034
11.2.3. Europe Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.2.4. Europe Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.2.5. Europe Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.2.6. Europe Antibody Discovery Market revenue (US$ Million) By End User, 2021-2034
11.2.7. Europe Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, 2021-2034
11.3.2. Asia Pacific Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, 2021-2034
11.3.3. Asia Pacific Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.3.4. Asia Pacific Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.3.5. Asia Pacific Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.3.6. Asia Pacific Antibody Discovery Market revenue (US$ Million) By End User, 2021-2034
11.3.7. Asia Pacific Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
11.4. Latin America
11.4.1. Latin America Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, (US$ Million) 2021-2034
11.4.2. Latin America Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, (US$ Million) 2021-2034
11.4.3. Latin America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.4.4. Latin America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.4.5. Latin America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.4.6. Latin America Antibody Discovery Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
11.4.7. Latin America Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, (US$ Million) 2021-2034
11.5.2. Middle East & Africa Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, (US$ Million) 2021-2034
11.5.3. Middle East & Africa Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.5.4. Middle East & Africa Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.5.5. Middle East & Africa Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.5.6. Middle East & Africa Antibody Discovery Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
11.5.7. Middle East & Africa Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Ablexis
12.2.2. Abwiz Bio
12.2.3. Abzena
12.2.4. Aragen Life Sciences
12.2.5. BIOTEM
12.2.6. ChemPartner
12.2.7. Creative Biolabs
12.2.8. DetaiBio
12.2.9. FairJourney Biologics
12.2.10. Fusion Antibodies
12.2.11. Genmab
12.2.12. Harbour BioMed
12.2.13. Immunome
12.2.14. ImmunoPrecise Antibodies
12.2.15. Integral Molecular
12.2.16. Isogenica
12.2.17. ProteoGenix
12.2.18. Syd Labs
12.2.19. Viva Biotech
12.2.20. WuXi Biologics
12.2.21. Others Market Players
Antibody Discovery Market By Antibody Discovery Step-
Antibody Discovery Market By Antibody Discovery Method -
Antibody Discovery Market By Nature of Antibody-
Antibody Discovery Market By Therapeutic Area -
Antibody Discovery Market By Type of Antibody-
Antibody Discovery Market By End-user
Antibody Discovery Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
